The Evidence Based Rheumatology Podcast
By Michael Putman
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Michael Putman
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 46
Reviews: 0
Episodes: 100
Description
A weekly podcast for physicians interested in evidence based medicine and rheumatology. Find the papers at ebrheum.com
| Episode | Date |
|---|---|
|
E111: PEXIVAS Subsets with Mike Walsh & Mats Junek
|
Mar 25, 2024 |
|
E110: Rheum4Debate - Screening for RA-ILD with Joshua Solomon and Scott Matson
|
Mar 14, 2024 |
|
E109: Abatacept for Pre-RA - the ARIAA Study
|
Mar 11, 2024 |
|
E108: Myositis Guidelines for Cancer Screening w/Alexander Oldroyd
|
Feb 26, 2024 |
|
E107: Fragility of SLE Randomized Controlled Trials
|
Feb 05, 2024 |
|
E106: GCA/PMR with Bhaskar Dasgupta
|
Jan 24, 2024 |
|
E105: Autoimmunity Post COVID-19?
|
Jan 09, 2024 |
|
E104: Sarilumab for PMR - The SAPHYR Study
|
Dec 14, 2023 |
|
E103: Len Calabrese on Monoclonal Antibodies for COVID-19
|
Oct 23, 2023 |
|
E102: Unintentional Unblinding in Rheumatic Disease Trials
|
Oct 16, 2023 |
|
E101: Pred v Colchicine for CPPD: COLCHICORT
|
Oct 02, 2023 |
|
E100: ADVOCATE Health Related Quality of Life
|
Sep 18, 2023 |
|
E99: Hospital Problems
|
Sep 07, 2023 |
|
E98: Key Opinion Leaders & ILD Guidelines
|
Aug 24, 2023 |
|
E97: Does allopurinol reduce CVD? The ALLHEART Study
|
Apr 27, 2023 |
|
E96: Long COVID - Where to After Norway?
|
Apr 13, 2023 |
|
E95: Rituximab or Cyclophosphamide in ANCA Vasculitis
|
Mar 30, 2023 |
|
E94: Steroids and Psoriasis Flares
|
Mar 16, 2023 |
|
E93: Azathioprine is the Worst
|
Mar 02, 2023 |
|
E92: Are muscle symptoms from statins imaginary?
|
Feb 16, 2023 |
|
E91: Clinical Innovation in Rheumatology: Past, Present, and Future
|
Dec 15, 2022 |
|
E90: There Is No Diagnosis of Exclusion in Rheumatology
|
Dec 01, 2022 |
|
E89: Vitamin D to Prevent Osteoporotic Fractures
|
Nov 10, 2022 |
|
E88: HCQ Dose Reductions and SLE Flares
|
Oct 27, 2022 |
|
E87: IVIG for Dermatomyositis
|
Oct 13, 2022 |
|
E86: Target Trials and Causality in Rheumatology
|
Jun 06, 2022 |
|
E85: Challenging Wisely
|
May 23, 2022 |
|
E84: The JAKapocalypse (AKA ORAL Surveillance)
|
May 09, 2022 |
|
E83: Effectiveness of COVID-19 Vaccines
|
Apr 25, 2022 |
|
E82: LoVAS Trial for ANCA Vasculitis
|
Nov 04, 2021 |
|
E81: Vasculitis Guidelines E7: Takayasu Arteritis with Dr. Andy Abril
|
Jul 12, 2021 |
|
E80: Vasculitis Guidelines E6 - Polyarteritis Nodosa with Dr. Jason Springer
|
Jul 11, 2021 |
|
E79: Vasculitis Guidelines E5 - GCA with Dr. Mehrdad Maz
|
Jul 10, 2021 |
|
E78: Vasculitis Guidelines #4 - EGPA with Dr. Phil Seo
|
Jul 09, 2021 |
|
E77: Vasculitis Guidelines #3 - ANCA Vasculitis with Dr. Sharon Chung
|
Jul 08, 2021 |
|
E76: Voclosporin for SLE Nephritis: The AURORA RCT
|
May 12, 2021 |
|
E75: Vasculitis Guidelines Episode 2: Overview with Sharon Chung
|
Apr 24, 2021 |
|
E74: Vasculitis Guidelines Episode 1 - Joyce Kullman
|
Apr 01, 2021 |
|
E73: Introducing the Vasculitis Guidelines Podcast
|
Mar 31, 2021 |
|
E72: Avacopan for ANCA Vasculitis
|
Feb 25, 2021 |
|
E71: MTX Discontinuation Post... Influenza Vaccination
|
Jan 27, 2021 |
|
E70: Rheum4Debate - HCQ Levels Should Be Monitored in Patients with SLE
|
Nov 19, 2020 |
|
E69: Publication Trends in SRMAs and RCTs
|
Oct 29, 2020 |
|
E68: SELECT-CHOICE Upadacitinib vs Abatacept in RA
|
Oct 15, 2020 |
|
E67: Belimumab in Lupus Nephritis (BLISS-LN)
|
Oct 01, 2020 |
|
E66: MRI to Diagnose PMR
|
Sep 10, 2020 |
|
E65: Anifrolumab in SLE - A Reply
|
Sep 03, 2020 |
|
E63: Housekeeping #3
|
Aug 27, 2020 |
|
E57: PEXIVAS Trial - PLEX and Reduced Steroid in ANCA Vasculitis
|
Feb 19, 2020 |
|
E56: Continue or Withdraw Prednisone in SLE (CORTICOLUP)
|
Feb 06, 2020 |
|
E55: Anifrolumab for SLE (TULIP 1&2)
|
Jan 23, 2020 |
|
E54: Rheum4Debate - Triple Tx is 1st Line in RA w/No Response to MTX
|
Jan 16, 2020 |
|
E53: Another Look at Nintedanib for SSc-ILD
|
Dec 19, 2019 |
|
E52: HOPE RCT - Prednisone for OA of the Hand
|
Dec 04, 2019 |
|
E51: Rheum4Debate - "Start TCZ Upfront in GCA"
|
Nov 26, 2019 |
|
E50: Housekeeping 2
|
Oct 24, 2019 |
|
E49: IL17i vs. TNFi for Psoriatic Arthritis (SPIRIT-H2H)
|
Oct 17, 2019 |
|
E48: ADACTA - Tocilizumab or Adalimumab in MTX Intolerant Patients with RA
|
Oct 03, 2019 |
|
E47: HCQ Blood Levels and HCQ Retinopathy
|
Sep 26, 2019 |
|
E46: Rituximab in Lupus
|
Sep 15, 2019 |
|
E45: TNF or TCZ or ABA or RTX: Real World Data for RA
|
Aug 29, 2019 |
|
E44: SELECT-COMPARE Upadacitinib (JAKi) for Rheumatoid Arthritis
|
Aug 15, 2019 |
|
E43: Tofacitinib for MDA5 Amyopathic Dermatomyositis ILD
|
Aug 08, 2019 |
|
E42: SENSCIS - Nintedanib for Systemic Sclerosis ILD
|
Jul 25, 2019 |
|
E41: Rheum4Debate "SLE Pts. on Cytoxan Should Receive Bactrim"
|
Jul 18, 2019 |
|
E40: Rheum4Debate - "SCT is 1st Line Tx for SSc ILD"
|
May 23, 2019 |
|
E39: MTX for GCA - 3 RCTs and a Case Control Study
|
May 09, 2019 |
|
E38: Romosozumab for Osteoporosis
|
May 02, 2019 |
|
E37: TRACE-RA Atorvastatin for Primary Prevention of CVD in RA
|
Apr 18, 2019 |
|
E36: Baricitinib for SLE
|
Apr 04, 2019 |
|
E35: Tramadol Associated with All Cause Mortality
|
Mar 29, 2019 |
|
E34: Leggo my Eggo! Eggs, Cholesterol, CVD, Mortality
|
Mar 21, 2019 |
|
E33: FDG-PET for GCA
|
Mar 15, 2019 |
|
E32: TaSER and ARCTIC: U/S to Guide Treatment in Inflammatory Arthritis
|
Mar 07, 2019 |
|
E31: SEAM and MIPA Trials: MTX vs. ETN for Psoriatic Arthritis
|
Feb 28, 2019 |
|
E30: The Quality of RCTs in the Rheum Literature
|
Feb 21, 2019 |
|
E29: CIRT and CANTOS - Immunotherapy for Cardiovascular Disease
|
Nov 21, 2018 |
|
E28: Nurse Run Treat to Target vs. Usual Care? in Gout
|
Nov 12, 2018 |
|
E27: Opioids vs. Non-opioids for OA Pain: The SPACE RCT
|
Nov 04, 2018 |
|
E26: Housekeeping 1
|
Oct 28, 2018 |
|
E25: MAINRITSAN 2 - Fixed vs. Tailored Rituxan for AAV
|
Oct 15, 2018 |
|
E24: Intra-articular Steroid vs. Placebo for Knee OA
|
Oct 01, 2018 |
|
E23: Stress Related Disorders and Subsequent Autoimmune Disease
|
Sep 20, 2018 |
|
E22: Ustekinumab for Giant Cell Arteritis
|
Aug 22, 2018 |
|
E21: ACE Levels for Sarcoidosis
|
Aug 13, 2018 |
|
E20: Rituxan vs. Cytoxan for AAV - The RAVE Trial
|
Aug 03, 2018 |
|
E19: Clinical Utility of a Positive ANA
|
Apr 30, 2018 |
|
E18: Triple Therapy for Catastrophic Antiphospholipid Syndrome
|
Apr 23, 2018 |
|
E17: Steroids and the Risk of Scleroderma Renal Crisis
|
Apr 16, 2018 |
|
E16: Tocilizumab in Giant-Cell Arteritis - GIACTA
|
Apr 09, 2018 |
|
E15: The Ribosomal P Isn't Useful in NPSLE
|
Apr 01, 2018 |
|
E14: Cardiovascular Safety of Febuxostat
|
Mar 25, 2018 |
|
E13: Withdrawing HCQ in SLE
|
Mar 18, 2018 |
|
E12: ACR 2015 Workforce Study - the Rheumageddon!
|
Mar 12, 2018 |
|
E11: Development and Validation of the HScore
|
Mar 04, 2018 |
|
E10: Abatacept in RA-ILD
|
Feb 23, 2018 |
|
E9: Rituximab in Myositis - The RIM Trial
|
Feb 21, 2018 |
|
E8: Mepolizumab or Placebo for EGPA
|
Feb 11, 2018 |
|
E7: The ALMS Trial - MMF vs CYC for Lupus Nephritis
|
Feb 04, 2018 |
|
E6: Methylprednisolone and Cyclophosphamide, Alone or in Combinatinon, for Lupus Nephritis
|
Jan 31, 2018 |